Venlafaxine-tramadol similarities

Medical Hypotheses

Volumn 51, Issue 2, 1998, Pages 167-168

  Markowitz, J S ^a   Patrick, K S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CIRAMADOL; MONOAMINE OXIDASE INHIBITOR; RESERPINE; TRAMADOL; VENLAFAXINE;

ANALGESIC ACTIVITY; ARTICLE; DEPRESSION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; MOLECULAR RECOGNITION; PAIN; PRIORITY JOURNAL;

EID: 0031826577     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90112-8     Document Type: Article

References (15)

1. Dwight M, Arnold L, O'Brien H, Metzger R, Morris-Park E. Venlafaxine treatment of fibromyalgia. Psychopharm Bull 1996; 32: 435.
2. Songer D A, Schulte H. Venlafaxine for the treatment of chronic pain. Am J Psychiatr 1996; 153: 737.
3. Galer B S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995; 12: S17-25.
4. Max M B, Lynch S A, Muir J, Shoaf S E, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-1256.
5. Fanelli J, Montgomery C. Use of the analgesic tramadol in antidepressant potentiation. Psychopharm Bull 1996; 32: 442.
6. Muth E A, Haskins J T, Moyer J A, Husbands G E, Nielsen S T, Sigg E B. Antidepressant biochemical profile of the novel bicyclic compound Wy-45, 030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35: 4493-4497.
7. Hennies H-H, Friderichs E, Wilsmann K, Flohe L. Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin. Biochem Pharmacol 1982; 31: 1654-1655.
8. Anonymous. Ultram product information. McNeil Pharmaceuticals, 1996.
9. Wang C P, Howell S R, Scatina J, Sisenwine S F. The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine. Chirality 1992; 4: 84-90.
10. Raffa R B, Friderichs E, Reimann et al. Complimentary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267: 331-340.
11. Bolden-Watson C, Richardson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52: 1023-1029.
12. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992; 105: 147-151.
13. Frink C M, Hennies H-H, Englberger W, Haurand M, Wilffert B. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneim-Forsch Drug Res 1996; 46: 1029-1036.
14. Bernstein J G. Receptors, drugs and neurotransmitters. In: Handbook of drug therapy in psychiatry. Littleton: PSG, 1998: 1-24.
15. Yardley J P, Morris Hubands G E, Stack G et al. 2-phenyl-2-(1-hydroxycycloalkyl) ethylamine derivatives: synthesis and antidepressant activity. J Med Chem 1990; 33: 2899-2905.